I am a computational biologist interested in transcriptional regulation in development and disease. I am currently a Principal Scientist at Omega Therapeutics, which is funded by Flagship Pioneering.

Till May 2017, I was a postdoc in the Meissner Lab in the Department of Stem Cell and Regenerative Biology (SCRB) at Harvard and affiliated with the Broad Institute. My research utilized genomic and epigenomic profiling to understand mechanisms of gene regulation that determine cellular identity, and I specialized in developing computational methods for the integrated analysis of large genome-wide datasets.